Subscribe free

Newsletter

Intestine and Lower Gastrointestinal Tract

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
J Clin Med25 Nov 2023

CT Staging Quirks: Unpacking the Nuances in Advanced Colon Tumor Diagnosis

In the quest for accurate preoperative staging of advanced colon tumors, the CT scan takes the stage. However, the spotlight reveals some hiccups. A national retrospective study with 1950 patients unfolded the CT's script, showing a 57% sensitivity in nailing T4 tumors, a 63% overall…

Dis Colon Rectum24 Nov 2023

Post-Surgery Employment: Japanese Colorectal Cancer Patients Achieve 79% Return Rate in 12 Months

Japanese colorectal cancer patients (stages I-III) witnessed promising employment outcomes within 12 months post-surgery, with a 79% return-to-work rate. The study identified risks for delayed return, including advanced tumor stage, stoma presence, severe complications, shorter work tenure, and lower return-to-work inclination. Factors contributing to unemployment…

Intestine and Lower Gastrointestinal Tract23 Nov 2023

Breaking Tradition: Bowel Preparations Questioned in Colo-Rectal Surgeries

In a retrospective dive into 1237 elective colo-rectal surgeries spanning 2008 to 2021, researchers challenged the long-standing use of mechanical bowel preparations (MBPs). No significant differences emerged between patients with MBPs, oral antibiotics, or no preparation, calling into question the routine use of MBPs in…

Br J Surg21 Nov 2023

Surgery Volume Matters: Risks in Low-Volume Centers for Colorectal Cancer.

A national study analyzing 16,883 cases across 80 centers unveils crucial associations. Low-volume centers show a 50% higher risk of severe postoperative complications, with reduced lymph node removal compared to high-volume centers. In rectal cancer cases, low-volume centers exhibit a 43% lower rate of adequate…

Intestine and Lower Gastrointestinal Tract20 Nov 2023

Preventing Obstruction: Identifying Risk Criteria for Colon Cancer Patients Undergoing Neoadjuvant Chemotherapy

In the FOxTROT trial, analyzing high-risk colon cancer patients undergoing neoadjuvant chemotherapy (NAC), researchers identified pre-treatment risk criteria to stratify obstruction risk. Among 699 patients, 4.3% developed obstruction. Two independent criteria, obstructing disease on endoscopy or inability to pass through the tumor, and stricturing disease…